Leucine enhances mitochondrial biogenesis and activates mTOR signaling in skeletal muscle while simultaneously decreasing STAT3 phosphorylation and associated inflammatory signaling in tumor-bearing mice (198, 199). The gene discussed is MTOR; the disease is neoplasm.